PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC9705435::ACT054506

Bradykinin

Evidence text

Paper-level observation

Table 4 entry 1: Bradykinin ex-vivo stability t1/2 5.29 ± 0.5 min
unknownConfidence: medium

Assay observation

Activity
Metabolic/Cardiovascular
Subtype
Other
Measure
other
Comparator
=
Raw observation
5.29 ± 0.5 min (half_life)
Normalized measurement
=5.29 other
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Mus musculus
Assay method
Not reported by source
Sequence
RPPGFSPFR
Standardization
ready simple

Source publication

Thiocarbazate building blocks enable the construction of azapeptides for rapid development of therapeutic candidates.

Nature Communications · 2022

DOI 10.1038/s41467-022-34712-9 PMC9705435
Parent mention Integrated peptide

Related peptide identities

PEPDIA-PLP-003998PEPDIA-INT-058212

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.